Letrozole’s ability to avoid an excessive elevation of luteinizing hormone (LH) minimizes the risk of hyperandrogenism and hormonal imbalances, unlike clomiphene citrate [18,19]. The gene discussed is PLOD1; the disease is hyperandrogenism.